• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然抗氧化剂可减轻诱导性1型强直性肌营养不良症胶质细胞模型中的氧化应激及RNA-CUG的毒性作用。

Natural Antioxidants Reduce Oxidative Stress and the Toxic Effects of RNA-CUG in an Inducible Glial Myotonic Dystrophy Type 1 Cell Model.

作者信息

Morales Fernando, Vargas Dayana, Palma-Jiménez Melissa, Rodríguez Esteban J, Azofeifa Gabriela, Hernández-Hernández Oscar

机构信息

Instituto de Investigaciones en Salud (INISA), Universidad de Costa Rica, San José 2060, Costa Rica.

Departamento de Bioquímica, Escuela de Medicina, Universidad de Costa Rica, San José 2060, Costa Rica.

出版信息

Antioxidants (Basel). 2025 Feb 25;14(3):260. doi: 10.3390/antiox14030260.

DOI:10.3390/antiox14030260
PMID:40227219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11939792/
Abstract

The toxic gain-of-function of RNA-CUG in DM1 has been largely studied in skeletal muscle, with little focus on its effects on the central nervous system (CNS). This study aimed to study if oxidative stress is present in DM1, its relationship with the toxic RNA gain-of-function and if natural antioxidants can revert some of the RNA-CUG toxic effects. Using an inducible glial DM1 model (MIO-M1 cells), we compared OS in expanded vs. unexpanded cells and investigated whether antioxidants can mitigate OS and RNA-CUG toxicity. OS was measured via superoxide anion and lipid peroxidation assays. RNA foci were identified using FISH, and the mis-splicing of selected exons was analyzed using semi-quantitative RT-PCR. Cells were treated with natural antioxidants, and the effects on OS, foci formation, and mis-splicing were compared between treated and untreated cells. The results showed significantly higher superoxide anion and lipid peroxidation levels in untreated DM1 cells, which decreased after antioxidant treatment (ANOVA, < 0.001). Foci were present in 51% of the untreated cells but were reduced in a dose-dependent manner following treatment (ANOVA, < 0.001). Antioxidants also improved the splicing of selected exons (ANOVA, < 0.001), suggesting OS plays a role in DM1, and antioxidants may offer therapeutic potential.

摘要

RNA-CUG在强直性肌营养不良1型(DM1)中的毒性功能获得主要在骨骼肌中进行了研究,很少关注其对中枢神经系统(CNS)的影响。本研究旨在探讨DM1中是否存在氧化应激,其与毒性RNA功能获得的关系,以及天然抗氧化剂是否可以逆转部分RNA-CUG的毒性作用。使用诱导性神经胶质DM1模型(MIO-M1细胞),我们比较了扩增细胞与未扩增细胞中的氧化应激,并研究了抗氧化剂是否可以减轻氧化应激和RNA-CUG毒性。通过超氧阴离子和脂质过氧化测定法测量氧化应激。使用荧光原位杂交(FISH)鉴定RNA病灶,并使用半定量逆转录聚合酶链反应(RT-PCR)分析选定外显子的错配剪接。用天然抗氧化剂处理细胞,并比较处理组和未处理组细胞对氧化应激、病灶形成和错配剪接的影响。结果显示,未处理的DM1细胞中超氧阴离子和脂质过氧化水平显著更高,抗氧化剂处理后降低(方差分析,P<0.001)。51%的未处理细胞中存在病灶,但处理后呈剂量依赖性减少(方差分析,P<0.001)。抗氧化剂还改善了选定外显子的剪接(方差分析,P<0.001),表明氧化应激在DM1中起作用,抗氧化剂可能具有治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/ba9103a4faf8/antioxidants-14-00260-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/91d96f28683f/antioxidants-14-00260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/0495754dd0e0/antioxidants-14-00260-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/43ee188b45b7/antioxidants-14-00260-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/5b70bc1cb156/antioxidants-14-00260-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/c37a9d94c559/antioxidants-14-00260-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/ba9103a4faf8/antioxidants-14-00260-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/91d96f28683f/antioxidants-14-00260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/0495754dd0e0/antioxidants-14-00260-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/43ee188b45b7/antioxidants-14-00260-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/5b70bc1cb156/antioxidants-14-00260-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/c37a9d94c559/antioxidants-14-00260-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66b9/11939792/ba9103a4faf8/antioxidants-14-00260-g006.jpg

相似文献

1
Natural Antioxidants Reduce Oxidative Stress and the Toxic Effects of RNA-CUG in an Inducible Glial Myotonic Dystrophy Type 1 Cell Model.天然抗氧化剂可减轻诱导性1型强直性肌营养不良症胶质细胞模型中的氧化应激及RNA-CUG的毒性作用。
Antioxidants (Basel). 2025 Feb 25;14(3):260. doi: 10.3390/antiox14030260.
2
Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1.转录组分析揭示了 1 型强直性肌营养不良诱导性神经胶质细胞模型中炎症途径的改变。
Biomolecules. 2021 Jan 26;11(2):159. doi: 10.3390/biom11020159.
3
Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy.口服红霉素可降低肌强直性营养不良的 RNA 毒性。
Ann Clin Transl Neurol. 2015 Dec 10;3(1):42-54. doi: 10.1002/acn3.271. eCollection 2016 Jan.
4
Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.呋咱甲氢龙通过多种机制挽救肌强直性营养不良 1 型相关的剪接错误。
ACS Chem Biol. 2018 Sep 21;13(9):2708-2718. doi: 10.1021/acschembio.8b00646. Epub 2018 Aug 27.
5
A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.一种新型的 CUG(exp)·MBNL1 抑制剂,具有治疗 1 型肌强直性营养不良的潜力。
ACS Chem Biol. 2013 May 17;8(5):1037-43. doi: 10.1021/cb400046u. Epub 2013 Mar 20.
6
Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells.扩展的CUG重复RNA在强直性肌营养不良模型细胞中诱导早衰。
Front Genet. 2022 Mar 25;13:865811. doi: 10.3389/fgene.2022.865811. eCollection 2022.
7
Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.用双脒基抑制剂靶向导致1型强直性肌营养不良症(DM1)的毒性RNA。
J Am Chem Soc. 2014 Apr 30;136(17):6355-61. doi: 10.1021/ja5012146. Epub 2014 Apr 22.
8
RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.靶向肌强直性营养不良小鼠模型中 CUG 重复的 RNA 干扰。
Mol Ther. 2013 Feb;21(2):380-7. doi: 10.1038/mt.2012.222. Epub 2012 Nov 27.
9
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.短反义锁核酸(全锁核酸)可纠正强直性肌营养不良中的异常剪接。
Nucleic Acids Res. 2015 Mar 31;43(6):3318-31. doi: 10.1093/nar/gkv163. Epub 2015 Mar 9.
10
Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1.1型强直性肌营养不良患者神经肌肉接头处的核糖核焦点。
Neuromuscul Disord. 2007 Mar;17(3):242-7. doi: 10.1016/j.nmd.2006.12.015. Epub 2007 Feb 15.

本文引用的文献

1
Reactive oxygen species and cell signaling. Review.活性氧与细胞信号传导。综述。
Biochim Biophys Acta Mol Cell Res. 2024 Feb;1871(2):119573. doi: 10.1016/j.bbamcr.2023.119573. Epub 2023 Nov 8.
2
Protein Phosphorylation Alterations in Myotonic Dystrophy Type 1: A Systematic Review.1 型肌强直性营养不良蛋白磷酸化改变:系统评价。
Int J Mol Sci. 2023 Feb 4;24(4):3091. doi: 10.3390/ijms24043091.
3
Superoxide Anion Chemistry-Its Role at the Core of the Innate Immunity.超氧阴离子化学——其在固有免疫中的核心作用。
Int J Mol Sci. 2023 Jan 17;24(3):1841. doi: 10.3390/ijms24031841.
4
Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes.强直性肌营养不良 RNA 毒性改变了小鼠和人星形胶质细胞的形态、黏附和迁移。
Nat Commun. 2022 Jul 4;13(1):3841. doi: 10.1038/s41467-022-31594-9.
5
Polyphenols and Their Effects on Muscle Atrophy and Muscle Health.多酚及其对肌肉萎缩和肌肉健康的影响。
Molecules. 2021 Aug 12;26(16):4887. doi: 10.3390/molecules26164887.
6
Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.1 型肌强直性营养不良(DM1)的临床亚型和围绕 CTG 扩展的 CTCF 位点甲基化状态与突变等位基因长度有关。
Hum Mol Genet. 2021 Dec 27;31(2):262-274. doi: 10.1093/hmg/ddab243.
7
Antioxidant Food Components for the Prevention and Treatment of Cardiovascular Diseases: Effects, Mechanisms, and Clinical Studies.抗氧化食物成分在心血管疾病预防和治疗中的作用、机制及临床研究
Oxid Med Cell Longev. 2021 Jan 28;2021:6627355. doi: 10.1155/2021/6627355. eCollection 2021.
8
Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1.转录组分析揭示了 1 型强直性肌营养不良诱导性神经胶质细胞模型中炎症途径的改变。
Biomolecules. 2021 Jan 26;11(2):159. doi: 10.3390/biom11020159.
9
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress.N-乙酰半胱氨酸(NAC)在氧化应激相关疾病中的多效治疗作用。
Curr Neuropharmacol. 2021;19(8):1202-1224. doi: 10.2174/1570159X19666201230144109.
10
A Review of Registered Clinical Trials on Dietary (Poly)Phenols: Past Efforts and Possible Future Directions.膳食(多)酚类物质注册临床试验综述:过去的工作及未来可能的方向
Foods. 2020 Nov 4;9(11):1606. doi: 10.3390/foods9111606.